PNC Financial Services Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $332K | Sell |
|
|||||
|
2024
Q4 | $671K | Sell |
|
|||||
|
2024
Q3 | $614K | Buy |
|
|||||
|
2024
Q2 | $517K | Buy |
|
|||||
|
2024
Q1 | $303K | Buy |
|
|||||
|
2023
Q4 | $272K | Sell |
|
|||||
|
2023
Q3 | $210K | Sell |
|
|||||
|
2023
Q2 | $452K | Buy |
|
|||||
|
2023
Q1 | $336K | Buy |
|
|||||
|
2022
Q4 | $311K | Sell |
|
|||||
|
2022
Q3 | $310K | Buy |
|
|||||
|
2022
Q2 | $336K | Sell |
|
|||||
|
2022
Q1 | $363K | Buy |
|
|||||
|
2021
Q4 | $246K | Buy |
|
|||||
|
2021
Q3 | $121K | Buy |
|
|||||
|
2021
Q2 | $86K | Sell |
|
|||||
|
2021
Q1 | $83K | Sell |
|
|||||
|
2020
Q4 | $82K | Hold |
|
|||||
|
2020
Q3 | $66K | Buy |
|
|||||
|
2020
Q2 | $57K | Hold |
|
|||||
|
2020
Q1 | $35K | Hold |
|
|||||
|
2019
Q4 | $77K | Buy |
|
|||||
|
2019
Q3 | $15K | Sell |
|
|||||
|
2019
Q2 | $27K | Buy |
|
|||||
|
2019
Q1 | $24K | Hold |
|
|||||
|
2018
Q4 | $23K | Hold |
|
|||||
|
2018
Q3 | $45K | Hold |
|
|||||
|
2018
Q2 | $37K | Buy |
|
|||||
|
2018
Q1 | $2K | Hold |
|
|||||
|
2017
Q4 | $0 | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $541K | Sell |
|
|||||
|
2016
Q2 | $1.41M | Sell |
|
|||||
|
2016
Q1 | $1.33M | Buy |
|
|||||
|
2015
Q4 | $71K | Sell |
|
|||||
|
2015
Q3 | $56K | Buy |
|